United StatesNorgestimate and Ethinyl Estradiol Tablets, USP (0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg) in 3x28 tablet blister cards per carton (Carton NDC 42291-565-84; Blister NDC 42291-565-28), Lot # LF41138A, exp 06/30/2027, manufactured for AvKARE, are being recalled nationwide in the U.S. The product was recalled because it failed content uniformity specifications.
What's being recalled
Norgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg, 3 Units, 3x28 tablets blister cards per carton, Rx only, Manufactured for AvKARE, Pulaski, TN 38478. Carton NDC: 42291-565-84; Blister NDC: 42291-565-28
Recalling firm: AvKARE, Pulaski, TN, United States.
How to identify it
Lot # LF41138A; Exp 06/30/2027
The hazard
Failed Content Uniformity Specifications
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
U.S. Nationwide
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)